Helping Organ Transplants Take

SangStat Medical (SANG) is not yet a household name. But it could become a lifesaver for people with transplants. SangStat makes a product that helps prevent the body from rejecting transplanted kidneys or livers. Such agents are called cyclosporines, and SangStat's version is expected to receive a patent soon--and get approval from the Food & Drug Administration in three to six months. So say some big players who have been accumulating the stock.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.